Ramsey, L B <br/><br/>
The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Oct 2014 
 - 423-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2014.125  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Interactions<br/>Genotype<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Liver-Specific Organic Anion Transporter 1<br/>Muscular Diseases--chemically induced<br/>Organic Anion Transporters--genetics<br/>Pharmacogenetics<br/>Polymorphism, Genetic<br/>Simvastatin--adverse effects